Home Blog Page 146

Blog

Pharma Marketing Blog

Most popular

Novo Nordisk Defends Choice of Paula Deen Over Anthony Bourdain (for...

Pharma Guy - January 19, 2012

Do We Really Need a Date Rape Drug Marketed for Fibromyalgia?

Pharma Guy - August 19, 2010

PhRMA (Intern) Finds Replacement for Billy Tauzin!

Pharma Guy - February 12, 2010

Consumer Reports Rip Rozerem Ad — A New One!

Pharma Guy - January 18, 2008

The Drug Advertising Blame Game

Pharma Guy - August 1, 2007

This Blogger’s Mission Statement

Pharma Guy - January 6, 2006

PhRMA Sent SiCKO Spy to Cannes

Pharma Guy - June 8, 2007

2015 New Year’s Resolutions for Pharma Marketers

Pharma Guy - December 29, 2014

#fdaSM Survey Results

Pharma Guy - March 1, 2010

Communicating Risk in Online Drug Ads: Reading the Tea Leaves in...

Pharma Guy - May 29, 2009

1...145146147...240 Page 146 of 240

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Researcher analyzing genetic data for an ultra-rare disease alongside physicians, DNA imagery, and patient silhouettes representing rare disease awareness and patient identification.

How Do You Market a Disease That Doesn’t Officially Exist?

August 6, 2026

Healthcare professional reviewing a plain-language clinical trial summary with a patient, illustrating how transparent communication strengthens trust, patient engagement, and pharmaceutical marketing.

The Plain-Language Revolution: How Compliance Is Becoming a Marketing Advantage

August 5, 2026

Healthcare professional reviewing a personalized medication dosing plan, illustrating flexible dosing strategies that support patient persistence and individualized treatment.

Could Flexible Dosing Become Pharma’s Next Competitive Advantage?

August 4, 2026